| 10/30/2019 | BK | PRA Health refinances with $1.75 billion two-tranche credit agreement
|
| 9/4/2019 | BK | Pharmaceutical Research gets $300 million incremental term loan
|
| 10/3/2017 | BKHY | S&P: PRA Health Sciences loan BB
|
| 2/28/2017 | BKHY | Moody’s lifts PRA, notes; rates facilities Ba3
|
| 1/25/2017 | BKHY | S&P lifts PRA Health, rates loan BB
|
| 6/25/2013 | BK | Moody's might downgrade Pharmaceutical Research Associates
|
| 2/28/2013 | BK | Market Commentary: RCN, Apple Leisure, SRS, Fibertech, Encompass, PRA, CPP break; Huntsman slides with add-on
|
| 2/25/2013 | BK | Pharmaceutical Research upsizes incremental loans to $95 million
|
| 2/25/2013 | BK | Market Commentary: Nielsen, TransDigm, Payless, Pro Mach, Ollie's break; primary sees a number of deal changes
|
| 2/19/2013 | BK | Moody's: PRA loans B1, Caa1
|
| 2/13/2013 | BK | Pharmaceutical Research launches $70 million of incremental loans
|
| 2/13/2013 | BK | Market Commentary: SuperValu, Saxon, First Advantage, Freescale, Calpine, Fariway, Landry's, Immucor free up
|
| 12/5/2012 | BK | Pharmaceutical Research firms first- and second-lien term loan pricing
|
| 12/5/2012 | BK | Market Commentary: Sensata, Hamilton, Blue Buffalo free up; Plains Exploration dips with acquisition news
|
| 11/27/2012 | BK | Pharmaceutical Research cuts first-lien loan size, adjusts pricing
|
| 11/27/2012 | BK | Market Commentary: GWF Energy frees up; Pharmaceutical Research Associates, Vesta tweak structures, pricing
|
| 11/16/2012 | BKDD | Moody's rates Pharmaceutical Research loans B1, Caa1
|
| 11/14/2012 | BK | S&P cuts Pharmaceutical Research, rates loans B, B-
|
| 11/13/2012 | BK | S&P: PRA on watch
|
| 11/7/2012 | BK | Pharmaceutical Research to launch $535 million facility on Tuesday
|
| 11/7/2012 | BK | Market Commentary: Chesapeake, Milk, nTelos break; Phoenix, Bass Pro, Multi Packaging, NewPage set talk
|
| 6/1/2012 | BK | Moody's rates PRA facility B1
|
